Get notified when DTIL files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsPrecision BioSciences files routine disclosure for DMD program webcast with KOLs
Filed March 17, 2026 · Period ending March 17, 2026 · ~1 min read
Key Changes
-
low
Company hosting March 17 webcast featuring key opinion leaders to discuss Duchenne muscular dystrophy treatment landscape and PBGENE-DMD program, including FUNCTION-DMD Phase 1/2 trial overview.
Item 7.01 verify on EDGAR → -
low
Filed presentation materials for the KOL event; disclosure is procedural investor relations activity with no material business developments announced.
Item 9.01 verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (TRV 10-Q) is open in full — no account needed.
Partner
Trade DTIL commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 4, 2026 · How we verify